Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5643308
[patent_doc_number] => 20060281763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Carboxamide inhibitors of TGFbeta'
[patent_app_type] => utility
[patent_app_number] => 11/390980
[patent_app_country] => US
[patent_app_date] => 2006-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24519
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281763.pdf
[firstpage_image] =>[orig_patent_app_number] => 11390980
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/390980 | Carboxamide inhibitors of TGFbeta | Mar 26, 2006 | Abandoned |
Array
(
[id] => 4753203
[patent_doc_number] => 20080161278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => '2-Azetidinyl-4-(1H-Pyrazol-3-Ylamino) Pyrimidines as Inhibitors of Insulin-Like Growth Factor-1 Receptor Activity'
[patent_app_type] => utility
[patent_app_number] => 11/909243
[patent_app_country] => US
[patent_app_date] => 2006-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41887
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20080161278.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909243
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909243 | 2-Azetidinyl-4-(1H-Pyrazol-3-Ylamino) Pyrimidines as Inhibitors of Insulin-Like Growth Factor-1 Receptor Activity | Mar 20, 2006 | Abandoned |
Array
(
[id] => 833638
[patent_doc_number] => 07396928
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-08
[patent_title] => 'Crystals of 5-[2-amino-4-(2-furyl) pyrimidin-5-yl]-1-methylpyridin-2(1H)-one and processes for preparing the same'
[patent_app_type] => utility
[patent_app_number] => 11/378315
[patent_app_country] => US
[patent_app_date] => 2006-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6886
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/396/07396928.pdf
[firstpage_image] =>[orig_patent_app_number] => 11378315
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/378315 | Crystals of 5-[2-amino-4-(2-furyl) pyrimidin-5-yl]-1-methylpyridin-2(1H)-one and processes for preparing the same | Mar 19, 2006 | Issued |
Array
(
[id] => 4813974
[patent_doc_number] => 20080194605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => '(1H-Ind0l-7-Yl)-(Pyrimidin-2-Ylamino)Methanone Derivatives and Related Compounds as Igf-R1 Inhibitors for the Treatment of Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/911268
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13502
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194605.pdf
[firstpage_image] =>[orig_patent_app_number] => 11911268
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/911268 | (1H-indol-7-yl)-(pyrimidin-2-ylamino)methanone derivatives and related compounds as IGF-R1 inhibitors for the treatment of cancer | Mar 16, 2006 | Issued |
Array
(
[id] => 5835431
[patent_doc_number] => 20060247262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => '2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/377716
[patent_app_country] => US
[patent_app_date] => 2006-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17979
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20060247262.pdf
[firstpage_image] =>[orig_patent_app_number] => 11377716
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/377716 | 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors | Mar 15, 2006 | Issued |
Array
(
[id] => 4866394
[patent_doc_number] => 20080145453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Novel Dihydropyrimidine Derivatives And Their Use As Anti-Cancer Agents'
[patent_app_type] => utility
[patent_app_number] => 11/908710
[patent_app_country] => US
[patent_app_date] => 2006-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4403
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145453.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908710
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908710 | Novel Dihydropyrimidine Derivatives And Their Use As Anti-Cancer Agents | Mar 13, 2006 | Abandoned |
Array
(
[id] => 4792767
[patent_doc_number] => 20080293741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Tricyclo Substituted Amides as Glucokinase Modulators'
[patent_app_type] => utility
[patent_app_number] => 12/091320
[patent_app_country] => US
[patent_app_date] => 2006-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6901
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293741.pdf
[firstpage_image] =>[orig_patent_app_number] => 12091320
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/091320 | Tricyclo Substituted Amides as Glucokinase Modulators | Mar 10, 2006 | Abandoned |
Array
(
[id] => 4813967
[patent_doc_number] => 20080194598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Pyrimidine Carboxylic Acid Derivatives and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/886289
[patent_app_country] => US
[patent_app_date] => 2006-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17803
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194598.pdf
[firstpage_image] =>[orig_patent_app_number] => 11886289
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/886289 | Pyrimidine Carboxylic Acid Derivatives and Use Thereof | Mar 6, 2006 | Abandoned |
Array
(
[id] => 4676957
[patent_doc_number] => 20080214588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Hiv Inhibiting 2-(4-Cyanophenyl)-6-Hydroxylaminopyrimidines'
[patent_app_type] => utility
[patent_app_number] => 11/814982
[patent_app_country] => US
[patent_app_date] => 2006-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7673
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214588.pdf
[firstpage_image] =>[orig_patent_app_number] => 11814982
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814982 | Hiv Inhibiting 2-(4-Cyanophenyl)-6-Hydroxylaminopyrimidines | Mar 1, 2006 | Abandoned |
Array
(
[id] => 5291023
[patent_doc_number] => 20090023753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => '1,3-Thiazole-5-Carboxamides Useful as Cancer Chemotherapeutic Agents'
[patent_app_type] => utility
[patent_app_number] => 11/885104
[patent_app_country] => US
[patent_app_date] => 2006-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26088
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023753.pdf
[firstpage_image] =>[orig_patent_app_number] => 11885104
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/885104 | 1,3-Thiazole-5-Carboxamides Useful as Cancer Chemotherapeutic Agents | Feb 23, 2006 | Abandoned |
Array
(
[id] => 813787
[patent_doc_number] => 07414060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-19
[patent_title] => 'Pyridine-2-carboxyamide derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/360085
[patent_app_country] => US
[patent_app_date] => 2006-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25404
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/414/07414060.pdf
[firstpage_image] =>[orig_patent_app_number] => 11360085
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/360085 | Pyridine-2-carboxyamide derivatives | Feb 22, 2006 | Issued |
Array
(
[id] => 4813971
[patent_doc_number] => 20080194602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Hiv Inhibiting 2-(4-Cyanophenylamino) Pyrimidine Oxide Derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/814958
[patent_app_country] => US
[patent_app_date] => 2006-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6752
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194602.pdf
[firstpage_image] =>[orig_patent_app_number] => 11814958
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814958 | HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives | Feb 19, 2006 | Issued |
Array
(
[id] => 5700719
[patent_doc_number] => 20060217404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Pyridylpyrimidine derivatives as effective compounds against prion infections and prion diseases'
[patent_app_type] => utility
[patent_app_number] => 11/350410
[patent_app_country] => US
[patent_app_date] => 2006-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14619
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217404.pdf
[firstpage_image] =>[orig_patent_app_number] => 11350410
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/350410 | Pyridylpyrimidine derivatives as effective compounds against prion infections and prion diseases | Feb 7, 2006 | Abandoned |
Array
(
[id] => 5410745
[patent_doc_number] => 20090124644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'HIV INHIBITING 2-(4-CYANOPHENYLAMINO) PYRIMIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 11/813772
[patent_app_country] => US
[patent_app_date] => 2006-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8646
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20090124644.pdf
[firstpage_image] =>[orig_patent_app_number] => 11813772
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/813772 | HIV INHIBITING 2-(4-CYANOPHENYLAMINO) PYRIMIDINE DERIVATIVES | Jan 26, 2006 | Abandoned |
Array
(
[id] => 5620086
[patent_doc_number] => 20060189620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Immunosuppressive effects of pteridine derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/275601
[patent_app_country] => US
[patent_app_date] => 2006-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 27506
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20060189620.pdf
[firstpage_image] =>[orig_patent_app_number] => 11275601
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/275601 | Immunosuppressive effects of pteridine derivatives | Jan 17, 2006 | Abandoned |
Array
(
[id] => 5398383
[patent_doc_number] => 20090318446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => '4-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in Therapy'
[patent_app_type] => utility
[patent_app_number] => 11/794449
[patent_app_country] => US
[patent_app_date] => 2006-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20358
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318446.pdf
[firstpage_image] =>[orig_patent_app_number] => 11794449
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/794449 | 4-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in Therapy | Jan 10, 2006 | Abandoned |
Array
(
[id] => 494784
[patent_doc_number] => 07211673
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-01
[patent_title] => '4-trifluoromethylpyrazolyl-substituted pyridines and pyrimidines'
[patent_app_type] => utility
[patent_app_number] => 11/325957
[patent_app_country] => US
[patent_app_date] => 2006-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11193
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/211/07211673.pdf
[firstpage_image] =>[orig_patent_app_number] => 11325957
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/325957 | 4-trifluoromethylpyrazolyl-substituted pyridines and pyrimidines | Jan 4, 2006 | Issued |
Array
(
[id] => 5777394
[patent_doc_number] => 20060106034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Drug efflux pump inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/320229
[patent_app_country] => US
[patent_app_date] => 2005-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78691
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20060106034.pdf
[firstpage_image] =>[orig_patent_app_number] => 11320229
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/320229 | Drug efflux pump inhibitor | Dec 28, 2005 | Abandoned |
Array
(
[id] => 4904589
[patent_doc_number] => 20080114003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Pyrimidinylisoxazole Derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/794180
[patent_app_country] => US
[patent_app_date] => 2005-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45370
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20080114003.pdf
[firstpage_image] =>[orig_patent_app_number] => 11794180
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/794180 | Pyrimidinylisoxazole derivatives | Dec 26, 2005 | Issued |
Array
(
[id] => 4760025
[patent_doc_number] => 20080312251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Aminopyrimidine Compounds and Their Salts, Process for Preparation and Pharmaceutical Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/794250
[patent_app_country] => US
[patent_app_date] => 2005-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11402
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312251.pdf
[firstpage_image] =>[orig_patent_app_number] => 11794250
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/794250 | Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof | Dec 25, 2005 | Issued |